BrainStorm

March 31, 2014

How Close Are We to an Approved Treatment? - Bernard Munos

Thumbnail

How Close Are We to an Approved Treatment? - Bernard Munos

About This Episode

A discussion with Bernard Munos, Founder of InnoThink, and named one of the 25 most influential people in biopharma by FiercePharma.  He discussed his analysis of the drug pipeline, the status of drugs in it, as well as his recommendations for how we can organize research more effectively and lower the cost of innovation and reduce the risk of failure so that we can get to a cure faster and at lower cost.

This call was made possible by the generous support of the Zickler Family Foundation.

BrainStorm Feed

62
May 7, 2024 | 19:58

More Men Are Becoming Alzheimer’s Caregivers. Advice from Former Wisconsin Governor Schreiber, Author of My Two Elaines: Learning, Coping, and Surviving as an Alzheimer's Caregiver

Traditionally two-thirds of unpaid family caregivers have been women, but that is changing.

LISTEN NOW
61
April 16, 2024 | 12:53

Dr. Brent Forester – The Complexity of Dementia Care and the Importance of a Holistic Approach (part 2)

Join us for part 2 of BrainStorm’s interview with Dr. Brent Forester, Chairman of the Department of Psychiatry, and Director of Behavioral Health at Tufts Medical Center.
LISTEN NOW
60
April 2, 2024 | 16:29

Dr. Brent Forester – The Complexity of Dementia Care and the Importance of a Holistic Approach (part 1)

If you're facing the challenge of caring for a parent with dementia, you are not alone. In this episode of BrainStorm Brent Forester, MD, MSc, Psychiatrist in Chief, Chairman of the Department of Psychiatry, and Director of Behavioral Health at Tufts Medical Center, discussed the complexity of dementia care and the importance of a holistic approach with host Meryl Comer.
LISTEN NOW